Sign in
4

Changes in Ownership

PTC THERAPEUTICS, INC. Filed Acc 0001415889-24-004106

CHIEF EXECUTIVE OFFICER acquired 70,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Klein Matthew B. CHIEF EXECUTIVE OFFICER 2024-02-15 Grant or award +70,000 230,475 D
Derivatives
Klein Matthew B. CHIEF EXECUTIVE OFFICER 2024-02-15 Grant or award · Stock Option (Right to Buy) +175,000 175,000 D
Loading xslF345X05/form4-02162024_040237.xml…